Back
Vision Lithium Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
38
ABEPF
Vision Lithium
Last Price:
$0.0200
Seasonality Move:
5.48%
Sell
46
REGN
Regeneron Pharmaceuticals
Last Price:
$563.00
Seasonality Move:
4.84%
Sell
38
Vision Lithium (ABEPF)
is a Sell
Is Vision Lithium a Buy, Sell or Hold?
-
The current Vision Lithium [ABEPF] share price is $0.0175. The Score for ABEPF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
ABEPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $563.00. The Score for REGN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABEPF Stock Price Chart
What is Vision Lithium's stock price today?
-
The Vision Lithium share price today is $0.0175Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABEPF is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $563.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
ABEPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 51.6 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0167 - 0.0167) | Buy |
| Bollinger Bands (100): | (0.016 - 0.016) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 156.06 | Buy |
| Relative Strength Index (14 RSI): | 54.32 | Buy |
| Chaikin Money Flow: | 26406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (547.59 - 566.53) | Buy |
| Bollinger Bands (100): | (524.11 - 609.13) | Sell |
ABEPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Buy |
| 20-day SMA: | 0.02 | Buy |
| 50-day SMA: | 0.02 | Buy |
| 200-day SMA: | 0.02 | Buy |
| 8-day EMA: | 0.02 | Buy |
| 20-day EMA: | 0.02 | Buy |
| 50-day EMA: | 0.02 | Buy |
| 200-day EMA: | 0.02 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 559.79 | Buy |
| 20-day SMA: | 558.03 | Buy |
| 50-day SMA: | 537.59 | Buy |
| 200-day SMA: | 657.55 | Sell |
| 8-day EMA: | 502.57 | Buy |
| 20-day EMA: | 332.66 | Buy |
| 50-day EMA: | 169.29 | Buy |
| 200-day EMA: | 48.17 | Buy |
Vision Lithium Earnings Growth & ABEPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.00 per share, an increase next quarter of $1.22 per share, a decrease this year of $5.66 per share, and an increase next year of $1.67 per share.
Vision Lithium Technical Analysis
| Jul 25 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 25 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||